Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
| ▸ | SLC26A4 | O43511 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | TERT | O14746 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GCG | P01275 | 1/20 | 0.32 |
| ▸ | GCGR | P47871 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2669958 | 0.90 | CASP3 (0.39) | CYP4F2CYP4A11KMT2AMEN1NPC1 | |
| SCHEMBL2669833 | 0.90 | CYP4F2 (0.39) | CYP4F2CYP4A11MAPTGCG | |
| SCHEMBL2669819 | 0.89 | CYP4F2 (0.36) | CYP4F2CYP4A11NPC1RAB9AMAPT | |
| SCHEMBL13069673 | 0.88 | CYP4F2 (0.36) | CYP4F2CYP4A11NPC1RAB9AGCG | |
| SCHEMBL2669939 | 0.86 | NPC1 (0.39) | NPC1RAB9A | |
| SCHEMBL2669836 | 0.85 | NPC1 (0.33) | KMT2ANPC1RAB9AGCG | |
| SCHEMBL2669782 | 0.85 | EGFR (0.36) | CYP4F2CYP4A11KMT2AMEN1NPC1 | |
| SCHEMBL9070786 | 0.85 | NPC1 (0.37) | NPC1RAB9A | |
| SCHEMBL2669955 | 0.84 | ESR1 (0.39) | NPC1RAB9A | |
| SCHEMBL9070778 | 0.83 | PTGS2 (0.42) | CYP4F2CYP4A11KMT2AMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2251326-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2010-11-17 | — | — | EP | disclosed |
| WO-2009110520-A1 | HETEROCYCLIC COMPOUND | 武田薬品工業株式会社 (JP) | 2009-09-11 | — | — | WO | disclosed |